drugset / Trial / NCT01646515

Udenafil Therapy to Improve Symptomatology, Exercise Tolerance and Hemodynamics in Patients With Chronic Systolic Heart Failure

NCT01646515

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if udenafil improves exercise tolerance in patients with systolic heart failure.

Timeline

Start
2011-12
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Udenafil Small molecule 100 mg